2018 AAPM Annual Meeting - Session: Pursuit of Safe and Effective Imaging and Radiation Therapy/Planning Products
|
 FDA's Role in the Regulatory Clearance of Safe and Effective Imaging and Radiation Planning and Delivery Products
William Jung, US Food & Drug Administration
|
When you have finished the video, you may
watch again,
browse/search all videos,
go back to the previous page, or watch another video in this session (see below).
add this video to a playlist.
All videos in this session:
Graph includes 34 member loads and 594 non-member loads (628 total loads).
Exclude non-member? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.
Radiotherapy Product Development;from Concept to a Clinical Device - Corey Zankowski, PhD Varian Oncology Systems
Imaging Product Development; From Concept to a Clinical Device - Erin Angel, PhD Canon Medical Systems
Quality Assurance Product Development; From Concept to a Clinical Device - William Simon, MS Sun Nuclear Corp
MITA's Role in the Development of Safe and Effective Imaging and Radiationplanning and Delivery Products - Patrick Hope, MITA
RO-SSI's Role in Facilitating Safety Improvements in Radiotherapy - Ramon Alfredo Siochi, PhD West Virginia University
Discussion - Jatinder Palta, PhD Virginia Commonwealth University
Q & A -